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Abstract
Background—Heart failure (HF) self-care interventions can improve outcomes, but less than
optimal adherence may limit their effectiveness. We evaluated if adherence to weight monitoring
and diuretic self-adjustment was associated with HF-related ED visits or hospitalizations.
Methods and Results—We performed a case-control analysis nested in a HF self-care
randomized trial. Participants received HF self-care training including weight monitoring and
diuretic self-adjustment, which they were to record in a diary. We defined cases as HF-related ED
visits or hospitalizations and the 7 preceding days; controls were defined as 7-day periods free of
ED visits and hospitalizations. We used logistic regression to compare weight monitoring and
diuretic self-adjustment adherence in cases and controls, adjusted for demographic and clinical
covariates. Among 303 participants, we identified 81 HF-related ED visits or hospitalizations
(cases) in 54 patients over one year of follow-up. Weight monitoring adherence (OR 0.42, 95% CI
0.23, 0.76) and diuretic self-adjustment adherence (OR 0.44, 95% CI 0.19, 0.98) were both
associated with lower adjusted odds of HF-related ED visits or hospitalizations.
Conclusions—Adherence to weight monitoring and diuretic self-adjustment was associated
with lower odds of HF-related ED visits or hospitalizations. Adherence to these activities may
reduce HF-related morbidity.
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Congestive Heart Failure; Compliance
Introduction
Weight monitoring and weight-based diuretic adjustment are frequently recommended as
part of heart failure (HF) self-care to reduce volume overload and prevent HF exacerbations,
though the evidence to support these recommendations is not robust.1,2 Even though HF
self-care programs have been associated with reduced hospitalizations in prior meta-
analyses,3,4 not all HF self-care clinical trials have demonstrated improved outcomes.3–6
Components vary among HF self-care programs, which may partially explain differences in
outcomes between trials. In addition, varying adherence to HF self-care programs may
explain differences in outcomes. Little is known about the effect of adherence to HF self-
care activities such as weight monitoring and diuretic self-adjustment on outcomes including
HF-related ED visits or hospitalizations.
To explore whether adherence to (1) weight monitoring or (2) weight-based diuretic self-
adjustment was related to the outcomes of HF-related ED visits or hospitalizations, we
conducted a nested case-control study within the intensive intervention arm of a randomized
clinical trial of HF self-care training.7 We hypothesized that optimal adherence with weight
monitoring and diuretic self-adjustment would be associated with lower odds of HF-related
ED visits or hospitalizations compared with less than optimal adherence.
Methods
We conducted a nested case-control study among 303 patients with HF who were assigned
to an intensive self-care intervention within a randomized controlled trial comparing
different levels of self-care training (ClinicalTrials.gov NCT0037950). Details of this trial,
including recruitment procedures and full inclusion and exclusion criteria, have been
described previously and will be summarized here.7 Briefly, patients participating in this
study were diagnosed with either systolic heart failure or heart failure with preserved
ejection fraction with New York Heart Association (NYHA) class II-IV symptoms within
the prior 6 months, were on a loop diuretic, had adequate cognitive function, and were fluent
in either English or Spanish. Patients were recruited between 2006 and 2009 from Internal
Medicine and Cardiology clinics at four academic institutions: University of North Carolina,
Northwestern University, Olive View – UCLA Medical Center, and University of
California, San Francisco – San Francisco General Hospital. Over the course of one year,
outcomes were collected, including death; all-cause and HF-related hospitalization; and all-
cause and HF-related ED visits. The Institutional Review Boards from each site approved
the protocol and all patients completed informed consent.
Description of the Intervention
Over the course of one year, intervention participants received an in-person 40 minute
education session followed by a median of 15 educator calls that reinforced weight
monitoring, taking proper diuretic doses, medication adherence, salt avoidance, and
exercise. Among the four educators who delivered the intervention, two were registered
dieticians with experience counseling patients in clinical settings; the other two had
bachelor's degrees and previous experience working as health educators. The educators
convened for a one day training prior to enrollment and participated in weekly calls with an
investigator to develop the educational protocol and ensure similar education delivery across
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sites. All participants were provided a digital bathroom scale and a specialized diary in
which they were to record their daily weight and diuretic dose. Participants who were
identified by their educator and provider as able to weigh daily and safely perform diuretic
self-adjustment were trained individually to perform weight-based diuretic self-adjustment
(72% of 303 intervention arm participants) as directed from a standardized algorithm,
termed the “Water Pill Guide” (Figure 1). Patients who were unable to weigh themselves or
whose providers felt that they could not safely perform this activity were not taught diuretic
self-adjustment. At enrollment the patient's provider identified the patient's euvolemic, or
“green zone” weight in this algorithm, for which patients were instructed to take their usual
diuretic dose. Patients were also taught to adjust their diuretic dose up or down if their
weight went into a “yellow zone,” defined by ± 4–7 pounds from their euvolemic weight. If
the patient's weight deviated from the target weight by 8 pounds or more into the “red zone,”
they were instructed to call their provider immediately in addition to taking the “yellow
zone” diuretic dose.
Participants were instructed to mail their weight and diuretic dose diaries back to the
educator on a monthly basis in self-addressed, stamped envelopes. The diaries were
reviewed by the educator to assess how well the participant was following the protocol and
to adjust the target/goal weight with the patient's provider as needed. Diaries were entered
into a database by trained study personnel at the conclusion of the study.
Data Collection
A trained research assistant (RA) at each site administered baseline questionnaires.
Socioeconomic status was measured with the MacArthur Scale of Subjective Social Status.8
Heart failure severity was assessed with structured questions and categorized by New York
Heart Association (NYHA) class. Literacy was measured with a Short Test of Functional
health Literacy in Adults (s-TOFHLA) and categorized into adequate literacy (≥ 23 out of
36) or inadequate/marginal literacy (< 23 out of 36).9 The RA abstracted medical records to
collect data about age; gender; prescribed medications including ACE-inhibitors,
angiotensin receptor blockers, and beta blockers; and comorbid conditions including atrial
fibrillation cardiovascular disease (TIA/stroke or prior MI or angina), chronic kidney disease
(eGFR < 60 mL/min/1.73m2), COPD, diabetes mellitus, hypertension, and systolic
dysfunction (ejection fraction <45% on echocardiogram).
The University of North Carolina Survey Research Unit collected clinical outcome data
from participants through telephone surveys at 1, 6, and 12 months. Participants were asked
about any ED visits, hospitalizations or other events that had occurred in the previous time
period, and if so, at which hospital(s) the event(s) took place. Upon identification of an ED
visit or hospitalization, admission and discharge summaries were requested from the
hospital. In addition, any other ED visits or hospitalizations occurring during a 6-month time
period at that site were also requested. A search for ED visits or hospitalizations was also
performed at the main clinical sites at 12-month follow up, regardless of whether the
participant reported outcomes at that site. The records were then reviewed by one of three
adjudication committee members masked to intervention status to determine if the
hospitalization was heart failure-related. Adjudication committee members used a study
protocol and their clinical judgment to determine whether HF was present and whether HF
was an important contributing factor to the ED visit or hospitalization, using a 5-point scale.
HF-related ED visits leading to hospitalizations during the same visit were categorized as
HF-related hospitalizations. The protocol used to define HF-related ED visits and
hospitalizations has been described previously in greater detail.7
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Defining Cases and Controls
The subject of interest in this analysis was the case or control time period. A case time
period was comprised of a HF-related ED visit or hospitalization and the 7-days preceding
this event. A control time period was comprised of no event (HF-related ED visit or
hospitalization) and the 7 days preceding this event-free day. The 7-day time period was
chosen based on findings from a prior study in which clinically important weight changes
occurred primarily in the 7 days preceding HF-related hospitalizations.10 We allowed all
individuals to contribute control time periods, even if they contributed a case time period at
another time; we also allowed all individuals to contribute multiple case and control time
periods (Figure 2).
In an effort to minimize differences for potentially confounding variables between case and
control time periods and to maximize the efficiency of our analysis, we matched 10 controls
for each case for age, gender, NYHA class, and study site. The first three matching variables
were chosen due to their prior association with HF-related outcomes.10–12 Study site was
selected as a matching variable due to differences in HF-related ED visits and
hospitalizations among the four study sites. The first 7 days following enrollment were
excluded from this analysis to allow patients time to establish a pattern of weight monitoring
and diuretic self-adjustment prior to assessing adherence.
During the study, 303 participants were enrolled in the intervention arm. Of these, 6 were
excluded from this analysis because they were unable to weigh themselves. Among the
remaining 297 individuals, we identified 90 case time periods in 54 individuals (case
individuals). Case time periods that contained additional ED visits or hospitalizations within
the 7 day time period (n = 9) were excluded. After exclusions, our analysis included 81 case
time periods in 54 case individuals (Figure 2).
After we excluded control time periods occurring in the first 7 days of the trial (n = 1,776)
and control time periods containing an ED visit or hospitalization (n = 2,000), we identified
102,544 potential control time periods in 297 individuals in which the 8th day did not
contain any ED visit or hospitalization (either all-cause or HF-related). Of the 102,544
potential control time periods, we identified 68,868 that matched to case time periods.
Several of the control time periods matched to multiple case time periods, generating
176,222 possible control pairings with the 81 case time periods. The number of control time
periods available as matches for each case time period ranged between 319 and 5,316. Of
these matches, 10 control time periods were randomly selected for each case time period.
After matching and random selection of control time periods, our analysis included 810
control time periods in 175 individuals (Figure 2). Of the 54 individuals contributing cases
(case individuals), 51 contributed at least one control time period as well.
Defining Adherence
Adherence to daily weight monitoring was determined from the 7 days of weight diary data
for each case or control time period and dichotomized into categories of ≥ 6 and < 6 out of 7
days to represent optimal and less than optimal weight monitoring adherence, respectively
Non-recorded and non-returned weight data were categorized as nonadherent. Adherence to
diuretic self-adjustment required (1) being taught and assigned to diuretic self-adjustment,
(2) recording a weight, and (3) agreement between the recorded diuretic dose and the
weight-dependent dose as recommended by the diuretic self-adjustment plan. Adherence to
diuretic self-adjustment was similarly dichotomized into categories of ≥ 6 and < 6 out of 7
days with non-recorded diuretic self-adjustment data categorized as nonadherent. The
optimal adherence threshold of ≥ 6 out of 7 days (≥ 85.7%) was chosen as it most closely
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approximates thresholds, ranging from > 75% to > 95% adherence, that are used to define
optimal medication adherence.13–16
Sensitivity Analyses
To address possible selection bias, we performed several sensitivity analyses. In our initial
sensitivity analyses to mitigate selection bias, both case and control periods were drawn
from the 54 case individuals. The effect of ≥ 6 out of 7 days' adherence to weight monitoring
and diuretic self-adjustment was evaluated using case time periods and all available control
time periods from case individuals (approximately 1 case time period: 322 control time
periods), adjusted only for within-case correlation. To address possible selection bias within
the diuretic self-adjustment analysis, we completed another analysis only among those
participants who were adherent to weight monitoring ≥ 6 out of 7 days (27 case time periods
and 270 control time periods). Our final analysis to address selection bias within the diuretic
self-adjustment analysis was performed only among those assigned to a diuretic self-
adjustment plan ≥ 6 days during the 7-day time period (41 case time periods and 410 control
time periods). For the latter two sensitivity analyses, matching and exclusion criteria were
otherwise identical to the main case-control analysis. Due to the small number of case time
periods in the latter two sensitivity analyses, we performed only unadjusted and minimally
adjusted analyses with matching variables (age, gender, NYHA class, and study site).
Because the optimal adherence thresholds for weight monitoring and diuretic self-
adjustment necessary to impart clinical benefit are unclear, we performed an additional set
of sensitivity analyses to examine adherence thresholds other than ≥ 6 out of 7 days. We
performed analyses using a higher 7 out of 7 day (100%) adherence threshold as well as
lower adherence thresholds of 5 out of 7 days (≥ 71.4%) and 4 out of 7 days (≥ 57%) for
weight monitoring and diuretic self-adjustment.
Statistical Analysis
We compared demographic, clinical and medication data in individuals who contributed
case and control time periods for descriptive purposes with a chi-square test for dichotomous
variables and Student's t-test for continuous variables. Continuous variables were evaluated
for normal distribution; we performed a Wilcoxon-Mann-Whitney test to compare case and
control individuals for continuous variables with a distribution that was not normal. We used
similar statistical methods to compare characteristics of case and control time periods, which
were not corrected for individuals who contributed multiple case and/or control time
periods.
We evaluated the effect of weight monitoring adherence preceding HF-related ED visits or
hospitalizations in case versus control time periods in both unadjusted and adjusted analyses
using conditional logistic regression for matched data.17 Diuretic self-adjustment adherence
was evaluated in case versus control time periods in the same manner. Minimally adjusted
analyses included only the matching variables (age, gender, NYHA class, and study site).
The fully adjusted analyses included the matching variables and subjective socioeconomic
status, literacy, cardiovascular disease, chronic kidney disease, and systolic dysfunction
given their potential to confound the association between adherence to weight monitoring or
diuretic self-adjustment and HF-related ED visits or hospitalizations. In addition, we
performed a cluster adjustment to account for individuals who contributed multiple case or
control time periods. We considered a two-sided p value of < 0.05 statistically significant.
All data analyses were performed using Stata 12.0 (College Station, TX).
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Table 1 shows characteristics at the individual level; case “individuals” are those who
contributed one or more case time periods at any point during the year of followup and
control “individuals” are those who contributed only control time periods during the year of
followup. Individuals who contributed both case and control time periods are characterized
as cases in this table. The mean age of the overall sample was 60.9 years, nearly half were
women (48%), and just over half had NYHA Class II HF (51%). Overall, case individuals
were similar to control individuals with regard to socio-demographic characteristics and
medication use. More case than control individuals had cardiovascular disease (57% vs.
37%), chronic kidney disease (54% vs. 33%), and systolic dysfunction (70% vs. 53%).
Individuals from the overall sample that contributed neither case nor control time periods
(n=119) were older compared to the individuals that contributed case and control time
periods (64.5 years versus 60.9 years). In addition, more of the individuals who contributed
neither case nor control time periods had NYHA class I HF and fewer had NYHA class II
HF compared to individuals contributing case and control time periods (Table 1).
The 81 case time periods included 12 ED visits (15%) and 69 hospitalizations (85%) related
to HF. Among the 54 case individuals contributing the 81 case time periods, 38 individuals
contributed 1 case time period each, 9 individuals contributed 2 each, and 7 individuals
contributed more than 2 case time periods. As shown in Table 2, the case and control time
period characteristics were overall comparable with regard to socio-demographic and
clinical characteristics with the exception of systolic dysfunction, which was present in 79%
of case versus 61% of control time periods.
The case and control time periods also differed in adherence (≥ 6 out of 7 days) to weight
monitoring (33% versus 48%, respectively) and adherence to diuretic self-adjustment (10%
versus 22%, respectively). In the overall sample of 891 time periods, 53% of weight
monitoring days (3304 of 6237 days) were categorized as nonadherent for weights, either
because a weight diary was not received (87% of nonadherent days) or because weight
values were not recorded on diaries that were received (13% of nonadherent days). In
addition, on 72% of days (4461 of 6237 days) from the overall sample, either weight or
diuretic dose diary data were incomplete or not received and categorized as nonadherent for
diuretic self-adjustment. Out of the overall sample of 297 individuals, 21% did not turn in
any diary with weight/diuretic doses for the entire study period; the proportion of individuals
that did not turn in a diary for the entire study was similar among cases (22%) and controls
(22%).
Effect of adherence to weight monitoring
Adherence to weight monitoring ≥ 6 out of 7 days yielded lower odds of HF-related ED
visits or hospitalizations (Table 3). This association was similar in magnitude for models
that were unadjusted (odds ratio (OR) 0.49, 95% CI 0.28–0.84), adjusted only for matching
variables (OR 0.46; 95% CI 0.27–0.78), and fully adjusted (OR 0.42, 95% CI 0.23–0.76).
Effect of adherence to weight-based diuretic self-adjustment
Diuretic self-adjustment adherence ≥ 6 out of 7 days was associated with lower odds of HF-
related ED visits or hospitalizations (Table 3). This association was also similar in
magnitude in models that were unadjusted (OR 0.43, 95% CI 0.20–0.95), adjusted only for
matching variables (OR 0.42, 95% CI 0.19–0.92), and fully adjusted (OR 0.44, 95% CI
0.19–0.98).
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Sensitivity analyses of weight monitoring and diuretic self-adjustment adherence of ≥ 6 out
of 7 days within case and control time periods drawn from the 54 case individuals were
attenuated but comparable to the results observed in the overall analyses (Table 3). In this
subanalysis, we found that odds ratios of HF-related ED visits or hospitalizations of 0.63
(95% CI 0.40–1.02) for weight monitoring adherence and 0.66 (95% CI 0.34–1.29) for
diuretic self-adjustment adherence.
In a subgroup analysis to evaluate adherence to diuretic self-adjustment among cases and
controls who were adherent to weight monitoring ≥ 6 out of 7 days (27 cases, 270 controls;
Table 3), we found that adherence to diuretic self-adjustment ≥ 6 out of 7 days yielded odds
ratios that were attenuated, but still comparable to the diuretic self-adjustment analysis from
the overall sample in unadjusted (OR 0.63, 95% CI 0.27–1.48) and minimally adjusted
analyses (OR 0.58, 95% CI 0.23–1.45).
Within a subgroup analysis among case and control time periods who were assigned to
diuretic self-adjustment for ≥ 6 days of the 7 day time period (41 cases, 410 controls; Table
3), we found that adherence to diuretic self-adjustment ≥ 6 out of 7 days had a comparable
but attenuated effect compared to the diuretic self-adjustment adherence analysis in the
overall sample, yielding lower odds of HF-related ED visits or hospitalizations in unadjusted
(OR 0.47, 95% CI 0.20–1.11) and minimally adjusted analyses (OR 0.39, 95% CI 0.17–
0.92). This suggests that selection bias did not contribute more than a modest amount to the
effect observed in the main analysis.
We performed sensitivity analyses of other weight monitoring adherence thresholds and
found similar odd ratios to the ≥ 6 out of 7 day threshold (Table 4). A 7 out of 7 day weight
monitoring adherence threshold (compared to <7/7 days) yielded an odds ratio of 0.35 (95%
CI 0.19–0.67 for HF-related ED visits or hospitalizations. Thresholds of ≥ 5 and ≥ 4 out of 7
days yielded odds ratios of 0.42 (95% CI 0.23–0.78) and 0.47 (95% CI 0.27–0.82),
respectively. We performed a similar sensitivity analysis for diuretic self-adjustment and
found that odds ratios for adherence thresholds of 7, ≥ 5, and ≥ 4 out of 7 days were
attenuated but comparable to the ≥ 6 out of 7 day threshold, yielding odds ratios of 0.49
(95% CI 0.21–1.13), 0.60 (95% CI 0.30–1.18), and 0.54 (0.27–1.11), respectively, for HF-
related ED visits or hospitalizations (Table 4).
Discussion
In a case-control study, we found that optimal adherence to weight monitoring and diuretic
self-adjustment were both associated with lower odds of a HF-related ED visit or
hospitalization compared with less than optimal adherence. This relationship was robust to
adjustment for possible confounders. In addition, the beneficial effect of adherence to
weight monitoring and diuretic self-adjustment persisted in subanalyses designed to
minimize selection bias. Our results suggest that optimizing adherence to weight monitoring
and diuretic self-adjustment could result in improved outcomes for patients with HF.
Prior meta-analyses have found that HF self-care programs reduce outcomes of
hospitalizations and mortality.3,4 In a recent Cochrane review that evaluated either
telemonitoring or structured telephone support for patients with HF, several studies involved
a component of weight monitoring in which participants were to weigh themselves at a
certain frequency and provide results to a research team.4 Within this review, we identified
ten studies18–26 that had a component of weight monitoring, of which five studies20,21,23–25
reported weight monitoring adherence. The five studies defined weight monitoring
adherence variably: two studies defined adherence as the proportion of weight or blood
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pressure transmissions received daily,21,24 one study defined adherence as the proportion of
telephone calls and weights completed at least every other day,20 and the final two defined
adherence as the proportion of weights received either daily25 or at least every other day.23
All five studies reported adherence levels that were ≥ 80% to their various measures; three
of the five studies also reported improvements in the intervention group compared to the
control group for outcomes including mortality, hospitalizations, and ED visits.20,21,23 In
contrast, 55.1% of patients were calling to report weights and symptoms at least three times
a week after 26 weeks of a weight telemonitoring study that did not find reductions in
hospitalizations or mortality.5 Although optimal adherence to weight monitoring has not
consistently been associated with improved outcomes,6,24,25 it is possible that less than
optimal adherence to HF self-care programs including weight monitoring may contribute to
differences in outcomes.
Although medication adherence in patients with HF has been associated with fewer all-cause
and HF-related hospitalizations as well as lower healthcare costs,27,28 whether adherence to
other self-care behaviors including weight monitoring and diuretic self-adjustment improves
outcomes is unclear. While important work in this area has been completed using self-
reported indices of self-management,29,30 few rigorous evaluations of adherence to daily
weight monitoring or diuretic self-adjustment have been completed. Evidence for weight
monitoring and diuretic self-adjustment adherence relies heavily on subgroup analyses from
larger studies. In the Auckland Heart Failure Management Study (AHFMS), a randomized
trial of 197 patients with HF to evaluate the effect of weight diaries, attendance in a HF
clinic, and HF education over 12 months, a subgroup analysis showed that any use of a diary
to record medication adherence, symptoms, and/or weights by participants (n=76) compared
to no use of a diary (n=24) was related to lower mortality (11% of diary users versus 46% of
non-users, p <0.0001) and more days alive and out of the hospital (334.7 days in diary users
versus 217.4 days in non-users, p <0.0001).31 In addition, participants who weighed
themselves at least once a week (n=51) compared to those who weighed themselves less
frequently (n = 25) also had fewer all-cause hospital admissions (71% versus 44%) and
more total days alive and not hospitalized (344 versus 210 days).31
Findings from our analysis in addition to those from the AHFMS suggest that improved
adherence to HF self-management programs including weight monitoring and diuretic self-
adjustment can improve outcomes. While multiple strategies may be effective in
encouraging HF self-care and improving outcomes, suboptimal adherence to even the most
beneficial strategy is likely to diminish related outcome improvements. We theorize that HF
self-care interventions are more likely to be effective if they include not only an effective
self-care program but also a strong component that promotes adherence to this program.
The ideal threshold to define adherence to self-care behaviors including weight monitoring
and diuretic self-adjustment is uncertain. The threshold used in the AHFMS analysis to
define “regular” weight monitoring was ≥1 out of 7 days. Within the Cochrane review of
telemonitoring for HF, a wide range of thresholds was used to define adherence to weights,
from once weekly to twice-daily weight monitoring.4,18,21,23–25 In prior research, a
medication adherence threshold of ≥88% has been associated with fewer events including
HF-related ED visits, cardiac rehospitalizations, and mortality.15 We explored higher and
lower adherence thresholds to both weight monitoring and diuretic self-adjustment to
evaluate if odds of HF-related ED visits or hospitalizations would change when compared to
our original ≥ 6 out of 7 day threshold. We found that different weight monitoring adherence
thresholds including 7, ≥5, and ≥4 out of 7 days yielded similar odds ratios for HF-related
ED visits or hospitalizations. A similar analysis for diuretic self-adjustment adherence
thresholds showed attenuated but similar odds ratios for HF-related ED visits or
hospitalizations across different levels of adherence.
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Observational studies are potentially subject to selection bias. The “healthy adherer effect”
has been used to describe the observation that optimal adherence not only to medications,
but also to placebo, has been associated with improved health outcomes, including
mortality.32,33 To address possible bias from the healthy adherer effect, we performed two
subanalyses: one within case individuals only and another within case and control time
periods with weight monitoring adherence of ≥ 6 out of 7 days. In both of these analyses, we
found attenuated but comparable odds ratios to our main analysis, which suggests that the
healthy adherer effect did not account for more than a small amount of the observed effect.
We addressed another form of selection bias within our diuretic self-adjustment analysis by
evaluating adherence to diuretic self-adjustment only among those assigned to a diuretic
self-adjustment plan for ≥ 6 out of 7 days. In this analysis, our findings were similar to our
main analysis of diuretic self-adjustment adherence, thus suggesting that this source of
selection bias did not substantially affect findings in our main analysis.
Our adherence exposure measurement could also have been a source of bias. We may have
under-estimated adherence because non-reported data was considered nonadherent, which
may have affected our results. However, failure to systematically record and mail in weights
and diuretic doses reflects deviation from the recommended self-care program that appears
meaningful. Finally, despite baseline differences in the prevalence of systolic dysfunction,
cardiovascular disease, and chronic kidney disease between case and control individuals, we
did not find that it affected our final results as all variables were accounted for in our fully
adjusted model.
With regard to the generalizability of our findings, our sample population had less advanced
HF by NYHA class and was younger compared to recent HF self-care studies.4,6 In addition,
it is unclear whether adherence to weight monitoring and diuretic self-adjustment would be
similarly beneficial outside of a clinical trial setting. Strengths of our study include a sample
that was drawn from multiple sites, availability of detailed socio-demographic data,
adjudicated outcome measurements for HF-related ED visits and hospitalizations, and the
novel assessment of diary-based weight monitoring and diuretic self-adjustment adherence
with sub-analyses to mitigate possible sources of bias
In conclusion, we found that optimal adherence to daily weight monitoring and weight-
based diuretic self-adjustment was associated with lower odds of HF-related ED visits or
hospitalizations. While our findings should be interpreted in the context of a case-control
study design, we conclude that optimizing adherence to weight monitoring and diuretic self-
adjustment as part of HF self-care may contribute to improved outcomes of HF-related ED
visits and hospitalizations. Further evaluation of adherence to weight monitoring and
diuretic self-adjustment as part of HF self-care may provide valuable insights about the
utility of interventions that teach these activities. Furthermore, enhancing adoption and
adherence for these self-care behaviors may be an important step in reducing HF-related
morbidity.
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Table 1















† 60.9 (13.8) 59.7 (14.2) 58.0 (12.9) 64.5 (13.9)
Men (N, %) 154 (52) 29 (54) 71 (57) 54 (45)
NYHA Class (N, %)
†
 I 52 (18) 7 (13) 10 (8) 35 (29)
 II 150 (51) 29 (54) 83 (67) 38 (32)
 III 61 (21) 12 (22) 22 (18) 27 (23)
 IV 34 (11) 6 (11) 9 (7) 19 (16)
Study Site (N, %)
 UNC 105 (35) 22 (41) 48 (39) 35 (29)
 Northwestern University 81 (27) 15 (28) 31 (25) 35 (29)
 UCSF 74 (25) 9 (17) 33 (27) 32 (27)
 Olive View, UCLA 37 (12) 8 (15) 12 (10) 17 (14)
Socioeconomic Status, median (interquartile
range)
‡ 4 (3, 6) 4 (2, 5) 4 (2, 6) 5 (3, 7)
Inadequate Literacy (N, %) 109 (37) 19 (35) 45 (36) 45 (38)
Cardiovascular Disease (N, %)
§ 131 (44) 31 (57) 46 (37) 54 (45)
Chronic Kidney Disease (N, %)
§ 128 (43) 29 (54) 41 (33) 58 (49)
Diabetes Mellitus (N, %) 148 (50) 28 (52) 60 (48) 60 (50)
Hypertension (N, %) 251 (85) 44 (81) 104 (84) 103 (87)
Systolic Dysfunction (N, %)
§ 167 (56) 38 (70) 66 (53) 63 (53)
ACE-Inhibitor or ARB (N, %) 235 (79) 43 (80) 99 (80) 93 (78)
Beta-Blocker (N, %) 237 (80) 45 (83) 103 (83) 89 (75)
Taught to perform diuretic self-adjustment (N,
%) 219 (74) 39 (72) 91 (73) 89 (75)
*
Excludes case individuals that contributed control time periods
†
p <0.001 comparing pooled “case and control individuals” to “neither case nor control individuals”
‡
No significant differences between groups by either t-test or Wilcoxon-Mann-Whitney test
§
p <0.05 comparing “case individuals” and “control individuals”
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Table 2
Characteristics of Case and Control Time Periods
Characteristics Combined Case and
Control Time Periods
(N=891)




Age, median (interquartile range)* 58.9 (49.9, 68.1) 57.6 (51.7, 65.5) 58.9 (49.9, 68.4)
Men (N, %) 484 (54) 44 (54) 440 (54)
NYHA Class (N, %)
 I 77 (9) 7 (9) 70 (9)
 II 495 (56) 45 (56) 450 (56)
 III 198 (22) 18 (22) 180 (22)
 IV 121 (14) 11 (14) 110 (14)
Study Site (N, %)
 UNC 385 (43) 35 (43) 350 (43)
 Northwestern University 264 (30) 24 (30) 240 (30)
 UCSF 169 (19) 13 (16) 156 (19)
 Olive View, UCLA 73 (8) 9 (11) 64 (8)
Socioeconomic Status, median (interquartile range)* 4 (3, 7) 4 (3, 5) 4 (3, 7)
Inadequate Literacy (N, %) 295 (33) 24 (30) 271 (33)
Cardiovascular Disease (N, %) 482 (54) 45 (56) 437 (54)
Chronic Kidney Disease (N, %) 353 (40) 39 (48) 314 (39)
Diabetes Mellitus (N, %) 396 (44) 39 (48) 357 (44)
Hypertension (N, %) 714 (80) 65 (80) 649 (80)
Systolic Dysfunction (N, %)
† 559 (63) 64 (79) 495 (61)
ACE-Inhibitor or ARB (N, %) 710 (80) 68 (84) 642 (79)
Beta-Blocker (N, %) 750 (84) 69 (85) 681 (84)
Adherent to weight monitoring
‡
 (≥ 6 out of 7 days; N,
%)
416 (47) 27 (33) 389 (48)
Assigned to diuretic self-adjustment(≥ 6 out of 7 days;
N, %)
540 (61) 41 (51) 499 (62)
Adherent to diuretic self-adjustment
‡
 (≥ 6 out of 7 days;
N, %)
184 (21) 8 (10) 176 (22)
*
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Table 3
Association of Adherence to Weight Monitoring and Diuretic Self-Adjustment with HF-Related ED Visits and
Hospitalizations; Secondary Analyses in Selected Subgroups
Models N (Time Periods) Odds Ratios 95% Confidence Intervals
Weight Monitoring Adherence (≥ 6 of 7 days) Among All Case and
Control Time Periods
Unadjusted 891 0.49 (0.28–0.84)
Minimally Adjusted* 891 0.46 (0.27–0.78)
Fully Adjusted
† 876 0.42 (0.23–0.76)
Diuretic Self-Adjustment Adherence (≥ 6 of 7 days) Among All Case
and Control Time Periods
Unadjusted 891 0.43 (0.20–0.95)
Minimally Adjusted* 891 0.42 (0.19–0.92)
Fully Adjusted
† 875 0.44 (0.19–0.98)
Weight Monitoring Adherence (≥ 6 of 7 days) Among Only Case
Individuals: All Available Case and Control Time Periods 
‡ 17416 0.63 (0.40–1.02)
Diuretic Self-adjustment Adherence (≥ 6 of 7 days) Among Only Case
Individuals: All Available Case and Control Time Periods 
‡ 17416 0.66 (0.34–1.29)
Diuretic Self-Adjustment Adherence (≥ 6 of 7 days) Among Case and
Control Time Periods With Weight Monitoring Adherence (≥ 6 of 7
days)
Unadjusted 297 0.63 (0.27–1.48)
Minimally Adjusted* 297 0.58 (0.23–1.45)
Diuretic Self-adjustment Adherence (≥ 6 of 7 days) Among Case and
Control Time Periods Assigned to Diuretic Self-Adjustment (≥ 6 of 7
days)
Unadjusted 451 0.47 (0.20–1.11)
Minimally Adjusted* 451 0.39 (0.17–0.92)
*
Models adjusted for variables: age, gender, NYHA class, and study site
†
Models adjusted for variables: age, gender, NYHA class, study site, socioeconomic status, literacy, cardiovascular disease, chronic kidney
disease, systolic dysfunction
‡
Models adjusted only for within-case correlation
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Table 4
Sensitivity Analysis of Variable Adherence Levels to Weight Monitoring and Adherence to Diuretic Self-
Adjustment with HF-Related ED Visits and Hospitalizations in Case and control Time Peridos
Models N (Time Periods) Odds Ratios 95% Confidence Intervals
Weight Monitoring Adherence Levels *
 7 of 7 days 876 0.35 (0.19–0.67)
≥ 6 of 7 days 876 0.42 (0.23–0.76)
≥ 5 of 7 days 876 0.42 (0.23–0.78)
≥ 4 of 7 days 876 0.47 (0.27–0.82)
Diuretic Self-Adjustment Adherence Levels *
 7 of 7 days 875 0.49 (0.21–1.13)
≥ 6 of 7 days 875 0.44 (0.19–0.98)
≥ 5 of 7 days 875 0.60 (0.30–1.18)
≥ 4 of 7 days 875 0.54 (0.27–1.11)
*
Models adjusted for variables: age, gender, NYHA class, study site, socioeconomic status, literacy, cardiovascular disease, chronic kidney
disease, systolic dysfunction
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